CRISPR Therapeutics to Present at the 28th Annual Piper Jaffray Healthcare Conference
November 22, 2016 08:00 ET
|
CRISPR Therapeutics AG
BASEL, Switzerland and CAMBRIDGE, Mass., Nov. 22, 2016 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on translating CRISPR-Cas9 gene-editing technology...
CRISPR Therapeutics Announces Two Presentations Demonstrating the Potential for CRISPR Gene Editing To Treat Sickle Cell Disease and β-Thalassemia
November 21, 2016 08:00 ET
|
CRISPR Therapeutics AG
BASEL, Switzerland and CAMBRIDGE, Mass., Nov. 21, 2016 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines...
CRISPR Therapeutics to Present at the Stifel 2016 Healthcare Conference
November 08, 2016 08:00 ET
|
CRISPR Therapeutics AG
BASEL, Switzerland and CAMBRIDGE, Mass., Nov. 08, 2016 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on translating CRISPR-Cas9 gene-editing technology...
CRISPR Therapeutics Announces Pricing of Initial Public Offering
October 18, 2016 21:59 ET
|
CRISPR Therapeutics AG
BASEL, Switzerland and CAMBRIDGE, Mass., Oct. 18, 2016 (GLOBE NEWSWIRE) -- CRISPR Therapeutics AG (Nasdaq:CRSP), a biopharmaceutical company focused on translating CRISPR/Cas9 gene-editing...